Literature DB >> 3871371

Immune T cells can protect or induce fatal neurological disease in murine lymphocytic choriomeningitis.

J E Allan, P C Doherty.   

Abstract

Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus. The elimination of virus from brain in the latter group, which survives without developing symptoms, depends upon the presence of Lyt 2+ lymphocytes. However removal of Lyt 2+ subset which is cytotoxic in vitro does not diminish the severity of the inflammatory process in vivo, though the onset of clinical disease is delayed in mice given Lyt 2-depleted populations and a larger ic dose of virus. The present findings are consistent with the idea that fatal LCM results from acute, synchronous damage to key functional cells in the central nervous system by virus-immune Lyt 2+, lymphocytes. Even so, if the number of virus-infected CNS cells is still relatively small at the time of T cell invasion, neurological symptoms are not recognized and the mice survive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871371     DOI: 10.1016/0008-8749(85)90204-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  18 in total

1.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 2.  Virus-immune T cells and the major histocompatibility complex: evolution of some basic concepts over the past two years.

Authors:  P C Doherty
Journal:  Experientia       Date:  1986-09-15

3.  The effect of lymphocytic choriomeningitis virus-induced suppression of the delayed-type hypersensitivity reaction on virus clearance and pathogenicity.

Authors:  O Marker; A R Thomsen
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

4.  Characteristics of the inflammatory process in murine lymphocytic choriomeningitis.

Authors:  P C Doherty; N A Bowern; J E Dixon; J E Allan
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Differential effect of hybrid resistance on the localization of virus-immune effector T cells to spleen and brain.

Authors:  P C Doherty; J E Allan
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 6.  The scientific challenge of Langerhans cell histiocytosis.

Authors:  P C Beverley; A K Abbas
Journal:  Br J Cancer Suppl       Date:  1994-09

Review 7.  Antibody-mediated clearance of viruses from the mammalian central nervous system.

Authors:  B Dietzschold
Journal:  Trends Microbiol       Date:  1993-05       Impact factor: 17.079

8.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Consequences of a single Ir-gene defect for the pathogenesis of lymphocytic choriomeningitis.

Authors:  J E Allan; P C Doherty
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 10.  Lymphocytic choriomeningitis infection of the central nervous system.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  Front Biosci       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.